Skip to main content
Clinical Trials/NCT02756923
NCT02756923
Completed
Not Applicable

Regulation of Stem Spermatogonia in the Mature Testis

Weill Medical College of Cornell University1 site in 1 country142 target enrollmentApril 2012

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
Male Infertility
Sponsor
Weill Medical College of Cornell University
Enrollment
142
Locations
1
Primary Endpoint
Levels of glial cell line derived neurotrophic factor (GDNF) in normal testis compared to abnormal testicular tissue obtained from infertile patients
Status
Completed
Last Updated
3 years ago

Overview

Brief Summary

Investigative trial to evaluate the role of a glial cell lined derived neurotrophic factor (GDNF) in regulation of spermatogonial renewal and testicular function. Goal of the trial is to provide greater information on the mechanisms that effect stem spermatogonial maintenance renewal and proliferation in its relation to male infertility.

Detailed Description

An essential requirement for sustaining male fertility is maintaining an adequate number of stem spermatogonia, the foundation of spermatogenesis. To achieve this, when the stem cells divide, some progeny must remain stem spermatogonia while other progeny differentiate. It is obvious that the correct balance between self-renewing replication and differentiation of stem spermatogonia is crucial to male fertility, and there is a indirect evidence that GDNF plays an important role in maintaining this balance in the normal mature testis. However, almost nothing is known about the in vivo regulation of this balance in the mature organ, of the specific function of GDNF in the adult testis, or if physiological changes in GDNF expression significantly affect the replication or differentiation of the stem cells. To address these critical issues, a unique mouse model that allows GDNF signaling to the stem spermatogonia to be specifically and reversibly inhibited in vivo by an ATP antagonist. With this model, the first direct evidence that GDNF is required for maintaining the stem spermatogonial pool in a normal mature testis. Additionally, the investigators have shown that when inhibition of GDNF signaling is reversed, the stem cells begin to rebuild the stem cell pool. Importantly, our data demonstrate that some stem spermatogonia are lost when GDNF signaling is inhibited for as little as 2 days, while other stem cells survive for up to 11 days. This suggests that factors intrinsic or extrinsic to the stem cells modulate the response to GDNF. Using this new mouse model the mechanisms responsible for the loss of stem spermatogonia proliferation and regeneration will be investigated along with GDNF signaling and inhibition. At the end of all of this these studies will be done on waste tissue obtained from normal men and men with infertility who otherwise have testicular surgery for therapeutic purposes.

Registry
clinicaltrials.gov
Start Date
April 2012
End Date
December 5, 2019
Last Updated
3 years ago
Study Type
Observational
Sex
Male

Investigators

Responsible Party
Sponsor

Eligibility Criteria

Inclusion Criteria

  • undergoing testicular biopsy at Weill Cornell Medicine/New York Presbyterian

Exclusion Criteria

  • females and any males outside of the age parameter of 18-75 years old

Outcomes

Primary Outcomes

Levels of glial cell line derived neurotrophic factor (GDNF) in normal testis compared to abnormal testicular tissue obtained from infertile patients

Time Frame: five years

Levels of glial cell line derived neurotrophic factor (GDNF) in normal testis compared to abnormal testicular tissue.

Study Sites (1)

Loading locations...

Similar Trials